Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Search Results (385)

    Sandborn, WilliamPerson Why?
    Selenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand.Academic Article Why?
    Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease.Academic Article Why?
    Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative.Academic Article Why?
    Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation.Academic Article Why?
    Crohn's disease complicated by strictures: a systematic review.Academic Article Why?
    Systematic review: Safety of balloon assisted enteroscopy in Crohn's disease.Academic Article Why?
    Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.Academic Article Why?
    Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis.Academic Article Why?
    Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index.Academic Article Why?
    SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis.Academic Article Why?
    Letter: Limitations of studies to evaluate the significance of anti-tumour necrosis factor serum levels in Crohn's disease--authors' reply.Academic Article Why?
    Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.Academic Article Why?
    Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease: Systematic review and meta-analysis.Academic Article Why?
    Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.Academic Article Why?
    Per Page    Page  of 26 Next
    Search Criteria
    • Crohn
    • s
    • disease
    Search Result Filters